Skip to main content

Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE: The National Infertility Association today announced a series of nationwide events to commemorate National Infertility Awareness Week (April 21-27, 2024).

“National Infertility Awareness Week sheds light on the profound impact of infertility, promoting compassion, empathy, and solidarity for the countless individuals struggling to build their family,” said Pete Anevski, CEO of Progyny. “As the preferred family building and women’s health provider for hundreds of the world’s leading employers, Progyny is committed to raising awareness and supporting all individuals on their path to parenthood.”

National Infertility Awareness Week events hosted by Progyny and RESOLVE include:

  • April 11th | ‘Fertility for All’ Panel Event (CA) – Progyny and RESOLVE, alongside partners Kellee Stewart (actress and award-winning fertility advocate) and Evite will host an event highlighting the importance of education, support, and access to family building care. Kellee Stewart to moderate with panelists including Rebecca Flick (Chief External Affairs Officer at RESOLVE), Dr. Janet Choi (Chief Medical Officer at Progyny), and Elizabeth Carr (first IVF baby born in the U.S.).
  • April 23rd | Ringing the Nasdaq Stock Market Closing Bell (NY) – Progyny, RESOLVE, leading employers, and industry notables who recognize the importance of providing comprehensive family building care will participate in the Closing Bell ceremony from 3:45 P.M. to 4:15 P.M. Eastern Time.
  • April 24th | Lighting of the Empire State Building (NY) – Progyny and RESOLVE will join acclaimed model, advocate, and entrepreneur Iskra Lawrence to light the top of the Empire State Building in orange, the official color for infertility awareness. This will be the third consecutive year the Empire State Building will be lit to support those faced with infertility.

“Being an advocate for others navigating their journey, I am deeply honored to participate in National Infertility Awareness Week alongside Progyny and RESOLVE,” says Iskra Lawrence. “Together, our goal is to raise awareness about this disease, eradicate the stigma surrounding it, advocate for accessible care, and come together in our shared mission to support those on their journey to parenthood.”

“RESOLVE expresses gratitude to Progyny for its support during National Infertility Awareness Week. By acknowledging this crucial movement, we help bring attention to the challenges one in six people will face on their journey to build families,” said Barbara Collura, President and CEO of RESOLVE. “In today’s climate, it’s imperative that we share our family building stories as we face unprecedented challenges to family building access for all. We call upon employers and policymakers to address this urgent issue and ensure that all family building options are legal, available and accessible to anyone who needs them.”

The Closing Bell ceremony will be webcasted online. If you’d like to view the ceremony live, visit https://www.nasdaq.com/marketsite/bell-ringing-ceremony. If you would like to learn more about the Empire State Building, visit https://www.esbnyc.com/about/tower-lights.

To learn more about Progyny, visit www.progyny.com. To learn more about RESOLVE, visit www.resolve.org.

About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building, and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients and physicians.

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women’s health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes’ Best Employers, Financial Times, Inc. 5000, Inc. Power Partners, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

About RESOLVE: The National Infertility Association
Established in 1974, RESOLVE: The National Infertility Association is a non-profit organization with the only established, nationwide network mandated to promote reproductive health and to ensure equal access to all family building options for the millions of people experiencing infertility or who face barriers to building a family. RESOLVE addresses this public health issue by providing community to these women and men, connecting them with others who can help, empowering them to find resolution and giving voice to their demands for access to all family building options. For more information, visit www.RESOLVE.org.

For Further Information, Please Contact:

Investors:
James Hart
investors@progyny.com

Media:
Alexis Ford
media@progyny.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.